All Articles on Vaccine
KPWHRI begins new phase of flu surveillanceKPWHRI receives $10 million to continue vaccine effectiveness research for flu, COVID-19, and other respiratory diseases
Gene-edited malaria vaccine warrants further studyEncouraging immune-response and safety data emerge from preliminary human test of genetically attenuated parasite vaccine.
Updated results from COVID-19 vaccine booster trialIDCRC study finds rapid decline in vaccine-boosted neutralizing antibodies against Omicron variant BA.5
COVID-19 vaccines safe for people who are pregnantNew data should increase confidence in vaccine safety among people who are pregnant and more at risk for COVID-19 complications.
Researchers begin clinical trial to assess schistosomiasis vaccineParticipant in KPWHRI trial receives world’s first-ever injection of investigational SchistoShield vaccination.
KPWHRI joins NIAID-sponsored study evaluating second COVID-19 booster shotsStudy includes multiple variant vaccines.
Volunteers needed for expanded COVID-19 booster trialNew arm of NIAID-sponsored mix-and-match trial will look at Novavax protein vaccine.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.